Telix Pharmaceuticals has introduced a new positron emission tomography (PET) radiochemistry solution, AlFluor.

PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

ClearNote Health has commenced subject enrolment in a multicentre, prospective study involving its Avantect pancreatic cancer ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, for pulmonary embolism ...

InspireMD’s CGuard Prime Embolic Prevention System (EPS) has secured CE Mark approval under the European MDR for stroke ...